2004至2018年美国接受腺样体扁桃体切除术儿童的多导睡眠监测与持续气道正压通气使用情况
该回顾性数据库分析纳入2004至2018年因睡眠症状接受腺样体扁桃体切除术的92,490名儿童,术前多导睡眠监测使用率为5.5%(唐氏综合征患儿为33.2%),术后多导睡眠监测和持续气道正压通气使用率均约3%。男性、肥胖、其他合并症、非白人种族/族裔及父母教育程度较高与术前和术后多导睡眠监测及持续气道正压通气使用相关。作者认为需要增加儿童公平获得多导睡眠监测的机会。
要点
- 92,490名儿童中术前多导睡眠监测使用率为5.5%,唐氏综合征患儿为33.2%。
- 术后多导睡眠监测使用率不足3%,约3%术后接受持续气道正压通气治疗。
- 男性、肥胖、非白人种族/族裔及父母教育程度较高与多导睡眠监测和持续气道正压通气使用相关。
核心结论
- 研究描述了腺样体扁桃体切除术前多导睡眠监测使用率以及术后针对持续症状的多导睡眠监测和持续气道正压通气使用率,并发现相关睡眠医疗保健差异。
- 作者认为需要增加儿童公平获得多导睡眠监测的机会,尤其是在腺样体扁桃体切除术后持续症状的评估和治疗中。
研究设计与样本
- 回顾性数据库分析,使用Optum(Health Services Innovation Company)数据识别2004至2018年间因睡眠症状接受腺样体扁桃体切除术的92,490名儿童。
- 比较有和无术前多导睡眠监测儿童的特征,并比较唐氏综合征(T21)高风险队列的多导睡眠监测和持续气道正压通气使用情况。
- 采用预测建模识别与术后多导睡眠监测和持续气道正压通气使用相关的患者特征。
主要发现
- 术前多导睡眠监测总体使用率为5.5%,唐氏综合征患儿为33.2%。
- 男性、肥胖、其他医学合并症、非白人种族/族裔及父母教育程度较高与术前多导睡眠监测相关。
- 术后多导睡眠监测使用率不足3%,约3%的儿童术后接受持续气道正压通气治疗。
- 多因素logistic回归显示,手术时年龄、男性、肥胖、其他医学合并症、非白人种族/族裔及父母教育程度较高与术后多导睡眠监测和持续气道正压通气使用相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: 1) To determine the prevalence polysomnogram (PSG) and continuous positive airway pressure (CPAP) therapy use in children who received adenotonsillectomy (AT) for sleep symptoms. 2) To identify health care disparities in these regards. STUDY DESIGN: Retrospective database analysis. METHODS: This study used data from Optum (Health Services Innovation Company) to identify 92,490 children who received AT for sleep symptoms between 2004 and 2018. Prevalence of preoperative PSG and postoperative PSG and CPAP were described. Clinical and demographic characteristics were compared between children who had preoperative PSG and those who did not. Characteristics of children with trisomy 21 (T21) were compared to assess PSG and CPAP use in a high-risk cohort. Predictive modeling was used to identify patient characteristics associated with postoperative PSG and CPAP use. RESULTS: Preoperative PSG was obtained in 5.5% of children overall and 33.2% of children with T21. Male sex, obesity, other medical comorbidities, non-White race/ethnicity, and higher parent education were associated with preoperative PSG. Fewer than 3% of children received postoperative PSGs and approximately 3% went on to receive CPAP therapy postoperatively. Multiple logistic regression showed that age at surgery, male sex, obesity, other medical comorbidities, non-White race/ethnicity, and higher parent education were associated with postoperative PSG and CPAP use. CONCLUSIONS AND RELEVANCE: This study described the prevalence pre-AT PSG use and post-AT PSG and CPAP use for persistent symptoms and identified sleep health care disparities in these regards. These results show that increased, equitable access to PSG is needed in children, particularly in the workup and treatment persistent symptoms after AT. LEVEL OF EVIDENCE: 4 Laryngoscope, 133:184-188, 2023.
引用
- Qian ZJ, Howard JM, Cohen SM, et al. Use of Polysomnography and CPAP in Children Who Received Adenotonsillectomy, US 2004 to 2018. Laryngoscope. 2022. PMID: 35285524. doi:10.1002/lary.30103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。